Suppr超能文献

重症社区获得性肺炎的重症监护管理、死亡率及预后指标

The intensive care management, mortality and prognostic indicators in severe community-acquired pneumococcal pneumonia.

作者信息

Potgieter P D, Hammond J M

机构信息

Department of Anaesthesia and Medicine, Groote Schuur Hospital, Cape Town, South Africa.

出版信息

Intensive Care Med. 1996 Dec;22(12):1301-6. doi: 10.1007/BF01709542.

Abstract

OBJECTIVE

To determine mortality and factors that might predict outcome in severe community-acquired pneumococcal pneumonia treated by a standard protocol.

DESIGN

Prospective, non-concurrent study.

SETTING

Respiratory intensive care unit (ICU) in a teaching hospital.

PATIENTS

63 patients who were diagnosed by positive blood culture or Gram stain and culture of sputum or tracheal aspirate were included.

MEASUREMENTS AND RESULTS

Clinical features, severity scores including Acute Physiology and Chronic Health Evaluation (APACHE) II, organ failure and lung injury scores, and the clinical course in the ICU were documented; 79% of patients required mechanical ventilation. Bacteraemia was present in 34 patients (54%); there were no distinguishing clinical features between bacteraemic and non-bacteraemic cases. The overall mortality was 21%, with only 5 deaths (15% mortality) in the bacteraemic group. Shock and a very low serum albumin (< 26 g/l) were the only clinical features that differentiated survivors from non-survivors; lung injury, APACHE II and multiple organ failure scores were all predictive of outcome. The positive predictive value and specificity in predicting death in individuals for the modified British Thoracic Society rule 1 were 26 and 64%; APACHE II > 2057 and 88%; > 2 organ failure 64 and 92%; and lung injury > 233 and 73%, respectively.

CONCLUSIONS

These results suggest that even in bacteraemic cases mortality should be below 25% with intensive care management and that conventional scoring systems, while predictive of group mortality, are unreliable in individuals.

摘要

目的

确定采用标准方案治疗的重症社区获得性肺炎的死亡率及可能预测预后的因素。

设计

前瞻性非同期研究。

地点

一家教学医院的呼吸重症监护病房(ICU)。

患者

纳入63例经血培养阳性或痰或气管吸出物革兰染色及培养确诊的患者。

测量与结果

记录临床特征、包括急性生理与慢性健康状况评估(APACHE)II在内的严重程度评分、器官衰竭和肺损伤评分以及ICU中的临床病程;79%的患者需要机械通气。34例患者(54%)存在菌血症;菌血症和非菌血症病例之间没有明显的临床特征差异。总体死亡率为21%,菌血症组仅有5例死亡(死亡率15%)。休克和极低的血清白蛋白(<26 g/l)是区分存活者与非存活者的唯一临床特征;肺损伤、APACHE II和多器官衰竭评分均能预测预后。改良英国胸科学会规则1预测个体死亡的阳性预测值和特异性分别为26%和64%;APACHE II>20为57%和88%;>2个器官衰竭为64%和92%;肺损伤>23为33%和73%。

结论

这些结果表明,即使在菌血症病例中,通过重症监护管理死亡率应低于25%,并且传统评分系统虽然能预测群体死亡率,但在个体中不可靠。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验